Experimental evaluation of aniline and methyl blue for intraocular surgery

Retina

Volumn 29, Issue 9, 2009, Pages 1266-1273

  Haritoglou, Christos ^a   Priglinger, Siegfried ^b   Liegl, Raffael ^a   May, Christian A ^c   Eibl, Kirsten ^a   Thaler, Sebastian ^d   Kampik, Anselm ^a   Schuettauf, Frank ^d  

^a UNIVERSITY OF MUNICH   (Germany)

^b KEPLER UNIVERSITY HOSPITAL   (Austria)

^c DRESDEN UNIVERSITY OF TECHNOLOGY   (Germany)

^d UNIVERSITY OF TÜBINGEN   (Germany)

Author keywords

Aniline blue; Macular surgery; Methyl blue; Vital dyes

Indexed keywords

3 (4,5 DIMETHYL 2 THIAZOLYL) 2,5 DIPHENYLTETRAZOLIUM BROMIDE; ANILINE BLUE; DYE; METHYL BLUE; UNCLASSIFIED DRUG;

ARTICLE; BIOCOMPATIBILITY; CELL PROLIFERATION; CELL VIABILITY; COLORIMETRY; CONTROLLED STUDY; EVALUATION; EYE SURGERY; FLUORESCENCE ANALYSIS; HUMAN; HUMAN CELL; PIGMENT EPITHELIUM; QUANTITATIVE ANALYSIS; RETINA MACULA LUTEA; STAINING; TOXICITY TESTING; VITRECTOMY;

ADULT; AGED; ANILINE COMPOUNDS; BASEMENT MEMBRANE; BENZENESULFONATES; CELL LINE; CELL PROLIFERATION; CELL SURVIVAL; COLORING AGENTS; FLUORESCENT DYES; HUMANS; MIDDLE AGED; RETINAL DISEASES; RETINAL PIGMENT EPITHELIUM;

EID: 70350172779     PISSN: 0275004X     EISSN: None     Source Type: Journal    
DOI: 10.1097/IAE.0b013e3181b8626f     Document Type: Article

References (36)

1. Wollensak G, Spoerl E, Wirbelauer C, Pham DT. Influence of indocyanine green staining on the biomechanical strength of porcine internal limiting membrane. Ophthalmologica 2004; 218:278-282. (Pubitemid 38969837)
2. Goldstein M, Zemel E, Loewenstein A, Perlman I. Retinal toxicity of indocyanine green in albino rabbits. Invest Ophthalmol Vis Sci 2006;47:2100-2107.
3. Feron EJ, Veckeneer M, Parys-Van Ginderdeuren R, Van Lommel A, Melles GR, Stalmans P. Trypan blue staining of epiretinal membranes in proliferative vitreoretinopathy. Arch Ophthalmol 2002;120:141-144.
4. Perrier M, Sebag M. Epiretinal membrane surgery assisted by trypan blue. Am J Ophthalmol 2003;135:909-911.
5. Burk SE, Da Mata AP, Snyder ME, Rosa RH Jr, Foster RE. Indocyanine green-assisted peeling of the retinal internal limiting membrane. Ophthalmology 2000;107:2010-2014.
6. Stalmans P, Van Aken EH, Melles G, Veckeneer M, Feron EJ, Stalmans I. Trypan blue not toxic for retinal pigment epithelium in vitro. Am J Ophthalmol 2003;135: 234-236.
7. Haritoglou C, Gandorfer A, Schaumberger M, et al. Trypan blue in macular pucker surgery: an evaluation of histology and functional outcome. Retina 2004;24:582-590.
8. Tsuiki E, Fujikawa A, Miyamura N, Yamada K, Mishima K, Kitaoka T. Visual field defects after macular hole surgery with indocyanine green-assisted internal limiting membrane peeling. Am J Ophthalmol 2007;143:704-705.
9. Haritoglou C, Gandorfer A, Gass CA, Schaumberger M, Ulbig MW, Kampik A. Indocyanine green-assisted peeling of the internal limiting membrane in macular hole surgery affects visual outcome: a clinicopathologic correlation. Am J Ophthalmol 2002;134:836-841. (Pubitemid 35425451)
10. Rodrigues EB, Meyer CH. Meta-analysis of chromovitrectomy with indocyanine green in macular hole surgery. Ophthalmologica 2008;222:123-129.
11. Yam HF, Kwok AK, Chan KP, et al. Effect of indocyanine green and illumination on gene expression in human retinal pigment epithelial cells. Invest Ophthalmol Vis Sci 2003;44:370-377.
12. Lai MM, Williams GA. Anatomical and visual outcomes of idiopathic macular hole surgery with internal limiting membrane removal using low-concentration indocyanine green. Retina 2007;27:477-482.
13. Hillenkamp J, Saikia P, Gora F, et al. Macular function and morphology after peeling of idiopathic epiretinal membrane with and without the assistance of indocyanine green. Br J Ophthalmol 2005;89:437-443.
14. Schuettauf F, Haritoglou C, May CA, et al. Administration of novel dyes for intraocular surgery: an in vivo toxicity animal study. Invest Ophthalmol Vis Sci 2006;47:3573-3578. (Pubitemid 351639726)
15. Haritoglou C, Yu A, Freyer W, et al. An evaluation of novel vital dyes for intraocular surgery. Invest Ophthalmol Vis Sci 2005;46:3315-3322.
16. Jackson TL, Griffin L, Vote B, Hillenkamp J, Marshall J. An experimental method for testing novel retinal vital stains. Exp Eye Res 2005;81:446-454.
17. Thaler S, Haritoglou C, Choragiewicz TJ, et al. In vivo toxicity study of rhodamine 6G in the rat retina. Invest Ophthalmol Vis Sci 2008;49:2120-2126.
18. Haritoglou C, Schüttauf F, Gandorfer A, Thaler S. An experimental approach towards novel dyes for intraocular surgery. Dev Ophthalmol 2008;42:141-152.
19. Dunn KC, Aotaki-Keen AE, Putkey FR, Hjelmeland LM. ARPE-19, a human retinal pigment epithelial cell line with differentiated properties. Exp Eye Res 1996;62:155-169.
20. Eibl KH, Banas B, Schoenfeld CL, et al. Alkylphosphocholines inhibit proliferation of human retinal pigment epithelial cells. Invest Ophthalmol Vis Sci 2003;44:3556-3561.
21. Grüntzig J, Nolte S, Schad P, Pfankuchen R. Lymph drainage of the cornea, limbus and conjunctiva. Klin Monatsbl Augenheilkd 1987;190:491-495.
22. Tiffet O, Nicholson AG, Khaddage A, et al. Feasibility of the detection of the sentinel lymph node in peripheral non-small cell lung cancer with radio isotopic and blue dye techniques. Chest 2005;127:443-448.
23. Hiebl W, Günther B, Meinert H. Substances for staining biological tissues: use of dyes in ophthalmology. Klin Monatsbl Augenheilkd 2005;222:309-311.
24. Lüke C, Lüke M, Dietlein TS, et al. Retinal tolerance to dyes. Br J Ophthalmol 2005;89:1188-1191.
25. Lüke C, Lüke M, Sickel W, Schneider T. Effects of patent blue on human retinal function. Graefes Arch Clin Exp Ophthalmol 2006;244:1188-1190.
26. Mennel S, Thumann G, Peter S, Meyer CH, Kroll P. Influence of vital dyes on the function of the outer blood-retinal barrier in vitro. Klin Monatsbl Augenheilkd 2006;223:568-576. (Pubitemid 44237893)
27. Ueno A, Hisatomi T, Enaida H, et al. Biocompatibility of brilliant blue G in a rat model of subretinal injection. Retina 2007;27:499-504.
28. Enaida H, Hisatomi T, Hata Y, et al. Brilliant blue G selectively stains the internal limiting membrane/brilliant blue G-assisted membrane peeling. Retina 2006;26:631-636. (Pubitemid 44620362)
29. Enaida H, Hisatomi T, Goto Y. Preclinical investigation of internal limiting membrane staining and peeling using intravitreal brilliant blue G. Retina 2006;26:623-630. (Pubitemid 44620361)
30. Lüke M, Januschowski K, Beutel J, et al. Electrophysiological effects of Brilliant Blue G in the model of the isolated perfused vertebrate retina. Graefes Arch Clin Exp Ophthalmol 2008;246:817-822.
31. Remy M, Thaler S, Schumann RG, et al. An in-vivo evaluation of Brilliant Blue G in animals and humans. Br J Ophthalmol 2008;92:1142-1147.
32. Chang YS, Tseng SY, Tseng SH, Chen YT, Hsiao JH. Comparison of dyes for cataract surgery. Part 1: cytotoxicity to corneal endothelial cells in a rabbit model. J Cataract Refract Surg 2005;31:792-798.
33. Chang YS, Tseng SY, Tseng SH. Comparison of dyes for cataract surgery. Part 2: efficacy of capsule staining in a rabbit model. J Cataract Refract Surg 2005;31:799-804.
34. Indig GL. In: Thomas J. Dougherty, ed. Optical Methods for Tumor Treatment and Detection: Mechanisms and Techniques in Photodynamic Therapy V. Proceedings of SPIE. Vol.2675. SPIE: San Jose, CA; 1997:228-237.
35. Lewis LM, Indig GL. Effect of dye aggregation on triarylmethane- mediated photoinduced damage of hexokinase and DNA. J Photochem Photobiol B 2002;67:139-148.
36. Indig GL, Anderson GS, Nichols MG, Bartlett JA, Mellon WS, Sieber F. Effect of molecular structure on the performance of triarylmethane dyes as therapeutic agents for photochemical purging of autologous bone marrow grafts from residual tumor cells. J Pharm Sci 2000;89: 88-99.